InvestorsHub Logo
Followers 2
Posts 1540
Boards Moderated 0
Alias Born 05/06/2017

Re: None

Tuesday, 11/09/2021 10:30:40 AM

Tuesday, November 09, 2021 10:30:40 AM

Post# of 2631
CloudMD Announces Preliminary Q3 2021 Financial Results.

source
https://finance.yahoo.com/news/cloudmd-announces-preliminary-q3-2021-123000505.html

Tue, November 9, 2021, 1:30 PM

- Q3 2021 is the first quarter that fully recognizes the financial results from all announced acquisitions.

- Q3 2021 preliminary revenue of $38 million to $40 million, with positive Adjusted EBITDA.
Adjusted EBITDA is defined as earnings before interest; taxes; depreciation; amortization; share-based compensation; financing-relating costs; acquisition-related and integration costs, net; litigation costs and loss provision; change in fair value of contingent consideration; and loss from discontinued operations.

- Increased annualized revenue run rate from $140 million to over $155 million demonstrating continued strong organic growth.

- CloudMD to reports Q3 2021 financial results on November 29, 2021 after market.


CloudMD Software & Services Inc. (TSXV: DOC, OTCQB: DOCRF, Frankfurt: 6PH), a healthcare technology company transforming the delivery of care, is pleased to announce its preliminary financial results for the three months ended September 30, 2021.

The three months ended September 30, 2021 is the first quarter the Company will fully recognize the financial results from all announced acquisitions, with the two largest acquisitions having closed near the end of June 2021. Based on its preliminary results, the Company anticipates revenue to be in range of $38 million to $40 million with positive Adjusted EBITDA for the quarter. CloudMD has also increased its annualized revenue run rate from $140 million to $155 million.

CloudMD will release its financial results for the three and nine months ended September 30, 2021, on Monday, November 29, 2021 after market close. Management will host an earnings conference call and webinar on the same day to review and discuss the quarterly operational highlights and financial results, followed by a question and answer period. Questions can be asked through the dial-in numbers only.

Conference call details:
Date and Time: Monday, November 29, 2021 at 5:00 pm Eastern Time (2:00 pm Pacific Time)
Toll-Free Dial-In Number: (833) 562-0117
International Dial-In Number: (661) 567-1009
Webcast Link: https://edge.media-server.com/mmc/p/nsy2gzh9

About CloudMD Software & Services
CloudMD is transforming the delivery of healthcare using technology and by providing a patient-centric approach, with an emphasis on continuity of care. By leveraging healthcare technology, the Company is building one, connected platform that addresses all points of a patient’s healthcare journey and provides better access to care and improved outcomes. Through CloudMD’s proprietary technology, the Company delivers quality healthcare through a holistic offering including hybrid primary care clinics, specialist care, telemedicine, mental health support, healthcare navigation, educational resources and artificial intelligence (AI). CloudMD’s Enterprise Health Solutions Division includes one of the top 4 Employee Assistance Programs in Canada and offers one comprehensive, digitally connected platform for corporations, insurers and advisors to better manage the health and wellness of their employees and customers.

CloudMD currently services a combined ecosystem of over 7,000 psychiatrists, approximately 4,500 therapists and counsellors, approximately 4,000 psychologists, over 22,000 family physicians, over 34,000 medical specialists, over 1,500 allied health professionals across North America.
For more information visit:
https://investors.cloudmd.ca/

ON BEHALF OF THE BOARD OF DIRECTORS
“Dr. Essam Hamza, MD"
Chief Executive Officer

FOR ADDITIONAL INFORMATION, CONTACT:
Julia Becker
VP, Investor Relations
julia@cloudmd.ca
(604) 785-0850